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Until there are valid identifiers that visualize stem cells in vivo, we rely upon flow cytometry to enrich for
subpopulations with stem cell function. However, data reporting styles for flow cytometric analyses are typi-
cally inconsistent, creating challenges in comparing results across publications. In our view, clear reporting
guidelines could improve reproducibility of stem cell analyses in solid tissues.Presently, the field of cancer stem cell
biology (and somatic stem cell biology in
general) is awash with reports of two-
parameter dot plots that do not resemble
one another, despite originating from
similar tissues immunophenotyped with
the same antibodies. Regardless of the
lack of resemblance to original publica-
tions, authors will often attribute specific
properties to cells that exhibit particular
phenotypic traits by flow analysis without
confirming their identity or function. Over-
all, this practice leads to the accumulation
of unvalidated conclusions and misinfor-
mation on the behavior of stem cells or
other cell types (such as differentiated
epithelial or nonepithelial cell types).
We encourage the community to make
use of the following proposed recommen-
dations for the presentation of stem cell
data obtained by flow cytometry. These
criteria are not new: broadly stated,
standards have been set out by MIBBI
(Minimum Information for Biological and
Biomedical Investigations), are outlined
by Lee et al. (2008), as a consensus of
opinion from cytometry professionals,
and have even been implemented as the
minimum accompanying information for
flow cytometric results by some journals.
Detailed criteria and techniques have
been discussed by Roederer and Herzen-
berg, especially with respect to setting
standards for hematopoietic cell analysis
(Herzenberg et al., 2006; Moore and Roe-
derer, 2009; Perfetto et al., 2006; Perfettoetal., 2004;Roederer, 2002a, 2008).Within
the broader stem cell community, how-
ever, there has been little standardization
applied to the separation of cell fractions
from solid tissues to date. This oversight
is unfortunate because the enzymatic
dissociation procedures that are used
for generating cell fractions make this
analysis even more variable than the anal-
ysis of nonadherent cell types. It seems
timely to highlight specific practices that
may offer the stem cell field improved
consistency in reporting across published
accounts, given the wildfire adoption of
cytometric procedures by laboratories
not previously specialized in multichro-
matic analyses of cell populations.
We propose that a detailed list of exper-
imental details and specific examples
be included in submissions that utilize
flow cytometric methods (Table 1). We
offer our insight as to how the provision
of such details will improve consistency
across related reportsandoutlinepotential
pitfalls that might be avoided by following
this pattern of experimental reporting.
There are many reasons why presenta-
tions of flow data derived from the same
tissue type may not look similar. Some
of these variables are hard to control for
and include differences between cytome-
ters (even the same model) or areas of the
world in which the experiments are con-
ducted. These issues can only be truly
solved by repeating all the functional
characterization in each independentCell Stem Cell 5,laboratory. Others sources of discrep-
ancy might be attributed to variability
between human tumors, to substantial
differences between profiles from inbred
mouse strains, or to different regimens
for proteolytic dissociation of tissues.
Specifically, the inclusion of the following
information should enable valid cross-
comparisons and ensure improved repro-
ducibility, as described below.
Antibody Binding Conditions Used
to Label Cell Populations
Flow cytometry is a quantitative tech-
nique when antibody binding is satu-
rating. Individual laboratories should take
pains to test ‘‘new’’ antibodies for satura-
tion binding (see Kantor and Roederer
(1997) as a source of information on basic
experimental guidelines). To describe
a staining reaction in enough detail that
it can be reproduced, the cell and anti-
body concentrations utilized should be
specified (within the limits of themanufac-
turer’s description; see Figures S1 and
S3). Indeed, the antibody clone and
specific fluorochrome used often influ-
ence the binding reactions in ways that
are difficult to rationalize, making the
provision of more detailed methodolog-
ical information important.
Make and Settings of the Flow
Cytometer
For the ability to reproduce functional
data from live cell sorts, machine factorsDecember 4, 2009 ª2009 Elsevier Inc. 579
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To Report in
Submitted




Establish consistency of antibody
binding immunophenotypes
Antibody clone and fluorochrome used; antibody
concentrations and time, temperatures used for
labeling
Figure S1
Make and settings of
the flow cytometer
Clarify any discrepancy in reporting
due to machine factors such as
physical pressures exerted, laser
calibration, wavelength, and
filters used
Make/model of cytometer used; nozzle tip
diameter, sheath pressure, and fluid composition;
laser power and wavelength used; software
package(s) used for sorting and analysis
Figures S1 and S3
Compensation
procedures
Achieve consistent elimination of
artifacts associated with spectral
overlap between fluorochromes
Report use of single stains or fluorescence-
minus-one stains; indicate whether compensation
was performed prior to separation and/or during
post-sort analysis; calculated by operator or with
a software-based algorithm
Figures S1, S3, and S5
Display of manual
gates applied
Improve equivalence of quantitation
across independent experiments
Display the gating hierarchy used; indicate the
number and percent of events excluded at each
step in the ‘‘tree’’; gates used to eliminate dead




Establish transparency of number
of events examined and reveal
degree of separation between
populations
Raw data plots demonstrating a sufficient event
count to establish an adequate ‘‘n’’; axis ticks that
distinguish between log and linear scales should be
visible; summary percentages should include a
degree of error determined in independent replicates
Figures S1–S5
Validation of results Evaluation of extent of purification
of isolated cells and verify their
functional status and degree of
enrichment
Reanalysis of fluorescent profile post-sort to
establish degree of sort purity; examination of
morphology and/or genetic traits to verify the
identity and purity of sorted cells; functional
assays comparing to similarly handled,
unselected cells are needed to determine fold
enrichment and degree of activity recovered
Figures S1, S5, and S6that can affect sample recovery, viability,
and function, such as nozzle tip diameter,
sheath pressure and fluid composition
should be reported (see examples in
figures in the Supplemental Data). The
laser power could be included, if this
figure is known to be an important deter-
minant of success. Note that these
settings differentially affect various cell
types; for example, for cells from the
mammary gland, high pressure and low
nozzle tip diameter can lead to fewer
differentiated cells or basal cells. Specifi-
cation of the make of the flow cytometer
and the name of the software package(s)
used during the sort and for any subse-
quent analysis provides most of the
important machine-based parameters
needed for background information.
There are a great diversity of options for
laser wavelengths and emission filters
and an expanding repertoire of new fluo-
rochromes (Chattopadhyay et al., 2008);
thus, the wavelength of the laser (and
possibly the emission filter, if that is not580 Cell Stem Cell 5, December 4, 2009 ª20predictable) should be stated, given that
these parameters can determine the rela-
tive efficiency of fluorochrome signals
(see Figures S1 and S3).
Compensation Procedures
For preserving the quantitative aspect
of flow cytometry, fluorescent signals
that bleed from one channel to another
should be subtracted. For example, if an
immunophenotyping reaction includes
a bright fluorochrome with an emission
spectrum that closely aligns with that
of other fluorochromes used in the
same sample, a correction factor will
be necessary to prevent cell populations
from being shifted inappropriately to
different quadrants of the dot plot. In
other words, cells that are labeled with
one bright fluorochrome may read as
false-positive expressors for a fluoro-
chrome with a closely overlapping emis-
sion spectrum. The correction factors
applied to prevent false-positive signals
are termed compensation procedures09 Elsevier Inc.(Roederer, 2002a), and a description of
compensation procedures used (single
stains for each dye, use of CompBeads
[Becton Dickinson], or lot numbers for
tandem dyes with variable spectral
properties, and whether the correction
is applied by the operator as either a
machine-based correction, or calculated
by software after flow cytometry [Her-
zenberg et al., 2006; Tung et al., 2004])
should be included in the methods
section (see Figures S1 and S3 for
examples, or http://www.drmr.com/ for
more detailed technical advice). Overall,
reproducible patterns and quantitation
of polychromatic flow histograms require
a consistent setup procedure. This
paradigm has been elegantly described
by Perfetto et al. and can be presented
as a stepwise dissection including sys-
tem optimization, calibration, and con-
tinuous monitoring of the fluorescent
signals with respect to sensitivity,
accuracy, and precision (Perfetto et al.,
2006).
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Accurate quantitation of cell subpopula-
tions depends as much on accounting
for the cells that are left out as the cells
that are included on the final data plot.
A description of the gating procedure
should include a list and display of the
sequential gates applied to exclude
debris, to select single cells, to assay
only live cells, and to exclude irrelevant
cells. This pattern is summarized in
a gating tree, also known as a population
hierarchy (see Figures S1 and S5). For
example, PI-positive cells (marking dead
cells with permeable membranes) and
debris can be ‘‘sticky,’’ and thus nonspe-
cifically bind antibody, and are likely to
emit autofluorescent signals that con-
tribute spurious, false-positive signals
(Figure S2). Cell doublets will bind propor-
tionally more antibody than single cells
and can often appear in stem cell frac-
tions, given that stem cell-enriched
fractions are often defined as ‘‘high’’ ex-
pressors of various cell surface antigens,
and so doublets should be gated out.
The typical 2D data plot relies on the
exclusion of cells not directly relevant to
the analysis because they will often
express ligands that bind the analytical
antibodies as well. Their presence can
cloud the view of rare target cells and
decrease the purity of a target population.
Themost common gate applied to epithe-
lial cell populations when attempting to
enrich for a rare stem or progenitor pool
is described as a Lineage+ gate (Lin+, or
‘‘dump channel,’’ based historically on
the application of a similar gate during
hematopoietic separations) and includes
a panel of antibodies labeled with the
same flurochrome that bind endothelial
and hematopoietic cells (such as CD31
and CD45). However, given that these
irrelevant populations are not completely
excluded by Lin+ antibodies (either
because cells are not homogeneously
positive or because the antigens are
clipped off cell surfaces during cell prepa-
ration), and their number can be high,
marking the location of these cells on
the final epithelial cell data plot can be
important for the accuracy of subsequent
interpretation (if for example, endothelial
cells overlie a putative stem cell-enriched
fraction; see Figure S2). Knowing where
any spurious populations from nonsub-
ject lineages lie on the final data plot
may convince the reader that anychanges in the fractions of interest are,
indeed, specific.
In addition to indicating how unwanted
events are eliminated, it is equally impor-
tant to clarify how a positive signal is
defined. Thus, for many antigens, an
unselected population exists as a con-
tinuum of negative-, low-, and high-stain-
ing cells, rather than as a collection of
obviously discrete populations. Subtrac-
tion of background binding can be based
on (in order of rigor): (1) a truly negative
population, for example genetically null
cells (see Figure S4), (2) a nonexpressing
population, known to be negative by prior
understanding (see Figure S3), or (3) rele-
vant singly stained fluorescently labeled
isotype-matched antibody controls and/
or fluorescence-minus-one strategies
(Roederer, 2002b; Tung et al., 2004) (see
Figure S3). Applying one or more of these
strategies is particularly important for rare
or specialized antigens, which are often
visualized by adding a labeled secondary
antibody that binds to the antigen-
specific primary antibody and are particu-
larly prone to high background binding
(Figure S4). Furthermore, if it is clear that
unstained cell populations exhibit signifi-
cant autofluorescence that is detected in
(all) analytical channels, the strategy
used to exclude this contribution should
be described. Many times, staining is
described by the subjective terms ‘‘high’’
and ‘‘low.’’ Instead, any cutoff used to
distinguish relative levels of staining
should be delimited quantitatively (for
example, ‘‘CD49flo cell fractions were
gated as the lower 50% of the popula-
tion,’’ or ‘‘the median fluorescence of the
CD49f lo was 10-fold less than that of the
CD49f hi cells’’; see Figure S3).
After having completed the gating hier-
archy, both to negatively and positively
select for the population of interest, it
should be clear what proportion of
cells is shown in the final analytical
window. For some cell preparations, the
total cell population represented on the
final flow data plot may be a relatively
minor fraction of the starting cell prepara-
tion. Thus, if one cell type is more suscep-
tible to damage than others (especially
with respect to the stem/differentiated
cell fractions), this trait could lead to large
discrepancies between laboratories (for
example, if one laboratory displays data
that represent 50%of the starting popula-
tion, whereas another presents 5%). ThatCell Stem Cell 5,is, without knowing which cells were lost
during the course of the gating procedure,
the final reported frequency of the popula-
tion of interest is impossible to compare
across laboratories.
Variations inoutcomedue tomechanical
susceptibilities of isolated cells might be
minimized by establishing a reproducible
pattern of cell release from solid tissues,
which is aided by providing detailed
information on mechanical disaggrega-
tion, cell-dissociation media, and agitation
patterns.Perhapscounterintuitively, tumor
cells are often more fragile than their
normal counterparts and easy to destroy
during preparation. Necrotic tumors con-
taining aneuploid cells may be particularly
hard to handle. Devising a method for
quality control for the enzymatic release
procedure is useful. For example, enzy-
matic digestion can strip epithelial cell
surface antigens, causing the epithelial
cells to appear at high frequency in other
nonepithelial populations. This effect can
be detected by analyzing nonepithelial
cell fractions for their expression of epithe-
lial keratins (such as keratin-5 or -8).
An estimate of the total number of
events retrieved from a flow cytometer,
compared to the cell number added to
the analysis tube, will often reveal serious
discrepancies that relate to the extensive
particles and debris that can be produced
during live-tissue processing. The number
of events is often assumed to equal the
number of cells, but this relationship
may not be accurate if/when epithelial or
tumor cells are disrupted into numerous
debris particles. The presence of scraps
of extracellular matrix can also contribute
to machine-detected ‘‘events’’ that are
actually debris. Thus, in cases where
significant debris is present, the percent
recovery of live cells may be significantly
higher than implied by the values reported
in the gating tree.
Display of the Raw Data
Flow cytometry follows the same rules of
reporting as other scientific assays; it
requires a sufficient n number (indepen-
dent sample determinations) to show
statistical significance. If the number of
independent assays is sufficient, the
absolute number of events required can
be low (Roederer, 2008). If a single data
plot is shown in a figure to illustrate the
properties and frequency of an enriched
population, these values should beDecember 4, 2009 ª2009 Elsevier Inc. 581
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mine on the basis of multiple independent
determinations. Note that axis ticks
should always be visible and clear (partic-
ularly to distinguish between logarithmic
and linear scales), and contour or other
density plots are often more visually
quantitative than dot plots. Finally, it
should be made clear whether methods
such as biExponential data transforma-
tion are used for visualizing compensated
data points that fall below the axis on
a logarithmic scale (Herzenberg et al.,
2006; Roederer et al., 2004).
Validation of Results: Evaluating
the Purity of Subpopulations
Cell fractions of interest should be char-
acterized after sort-mediated purification
(using relevant assays, such as cytospin-
immunohistochemistry [see Figure S1] or
genetic tests), with the aim of confirming
their identity. Note that claims of purity
are also supported by reanalysis of
sorted cell fractions, but these methods
can harbor false negatives if antibodies
or antigens and/or epitopes are lost
during mechanical separation or because
of photo-bleaching of particular fluoro-
chromes (resulting in an underestimate
of the sort efficiency). When various cell
populations are tested to determine their
functional activity, their relative viability
should be specified (using a live-cell
reporter such as trypan blue). Ideally,
enriched fractions should be compared
to stained, unseparated populations that
have also passed through the sorting
apparatus, to control for loss of function
due to mechanical shear or other stress
such as temperature or nutrient shock
(Figure S6).
Among the purest stem cell pop-
ulations reported to date are the hemato-
poietic stem cells (R1 in 3) purified by
Morrison and colleagues (Kiel et al.,
2005). Isolated fractions that harbor rela-
tively more cells with stem cell activity
should be labeled stem cell-enriched
(SCE), rather than ‘‘stem cells’’ (see
Figure S5), given that this label can be
misleading for readers and is often in-
correctly summarized in media sound
bites. For example, the MRU mammary
stem cell fraction, although it contains
all the stem cell activity isolated from
this tissue, may still be only 5% pure
(Shackleton et al., 2006; Stingl et al.,
2006; Figure S6).582 Cell Stem Cell 5, December 4, 2009 ª20Experiments that claim to enrich for
stem cell activity must be validated via
experimental means to show that func-
tional enrichment has, indeed, been
accomplished. Thus, the nonpurified cell
population should be compared with puri-
fied cell fractions, recording the percent
recovery of activity and fold-enrichment
(per cell) to illustrate how much of the
functional activity has been accounted
for (Figure S6). It is important to perform
functional analyses on all cell subsets,
including those claimed to be stem cell
deficient. The process of flow sorting itself
can compromise stem cell activity by
separating the test population from non-
stem cell types usually required to
support stem cell activity or because of
mechanical damage, blocking functional
epitopes with cell surface-binding anti-
bodies, or antigenicity of fluorochromes
(together, often responsible for 90% loss
of activity) (Britt et al., 2009). Importantly,
for specific claims about stemness to be
made, there should be a functional evalu-
ation of stem cell activity.
Concluding Thoughts
To summarize, we encourage authors and
reviewers to keep the following questions
in mind when assessing whether sub-
mitted cytometric data is sufficient to
support the claims made in a given study:
Are the methods described in sufficient
detail that the experiment can be repro-
duced, and do they include procedures
for mechanical and enzymatic dissocia-
tion, antibody sources and binding reac-
tions, make and settings for the flow
cytometer, and any relevant software?
For any major findings, are the gating
procedures presented, and is the ratio-
nale for gate placement clearly defined?
Are the relevant controls present that
confirm specificity of staining? Is the over-
all percent cell recovery presented? Is the
reproducibility of fractionation indicated?
What is the basis for correlating a specific
population with an activity or a pheno-
type? Is the percent purity presented for
any given phenotype in a cell fraction? If
functional activities are presented, what
is the percent activity recovered in puri-
fied cell fractions compared to the starting
population? Are the cell fractions given
accurate names? That is, if a subpopula-
tion is described as stem cell enriched,
what is the estimated percentage of
purity? What efforts are made to deter-09 Elsevier Inc.mine whether surrogate stem cell markers
are accurate and truly specific to the stem
cell-containing fraction?
It is typically expensive and time
consuming to set up flow cytometric
analyses of animal or human tissues,
especially when searching for rare popu-
lations. We hope that widespread adop-
tion of reporting guidelines, such as those
outlined previously (Lee et al., 2008) and
those we propose here for the analysis
of cells from solid tissues, will enable the
comparison of data generated across
laboratories worldwide to yield more
accurate conclusions and to reduce the
frustration of new investigators in this
area.
SUPPLEMENTAL DATA
Supplemental Data include six figures and can be
found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00581-5.
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